Skip to main content

Table 7 EBV gene expression levels and infection programs detected in CSF cells and PBMC from five RRMS patients

From: Immune and Epstein-Barr virus gene expression in cerebrospinal fluid and peripheral blood mononuclear cells from patients with relapsing-remitting multiple sclerosis

Patient code/sex, age

Time since diagnosis (months)

EDSS

Clinical condition

Gadolinium enhancement on MRI

IgG index

Cells/μl CSF

CSF

PBMC

EBV RNA speciesa

EBV infection program

CD19 RNAa

CD20 RNAa

GAPDH RNA (Ct)

EBV RNA speciesa

EBV infection program

CD19 RNAa

CD20 RNAa

GAPDH RNA (Ct)

FI01/F 25 years

<1

1

Relapse

Present

0.90

2

n.d.

–

0.02

0.02

20.5

EBER1 0.00003

Latency 0 program

0.05

0.19

13.7

TO41/F 37 years

15

1

Remission

Absent

2.07

14

EBER1 0.00015

Latency II or default program

0.08

0.18

17.4

EBER1 0.000017

Latency 0 program

0.008

0.35

13.6

LMP2A 0.0001

TO32/F 35 years

5

2

Relapse

Present

0.67

10

LMP1 0.00023

Latency II or default program

0.05

0.13

18.2

n.d.

–

0.08

0.20

15.6

CA07/F 22 years

17

1

Remission

Absent

0.78

5

n.d.

–

0.13

0.19

19.7

LMP1 0.00008

Latency II or default program

0.04

0.37

16.8

FI13/M 51 years

<1

1

Relapse

Present

0.81

7

EBER1 0.0003

Lytic program

0.01

0.07

17.3

EBER1 0.00035

Latency III or growth program

0.07

11.7

18.6

BZLF1 0.00009

(immediate early gene)

   

EBNA1 0.0004

EBNA3A 0.0004

 

gp350/220 0.0012

  1. Demographic, clinical, MRI, and CSF data of five RRMS patients with detectable EBV transcripts in CSF cells and/or PBMC are shown together with expression values of individual viral genes, B-cell related genes (CD19, CD20), and the housekeeping gene GAPDH in the corresponding samples
  2. n.d. not detected
  3. aGene expression values are presented as 2^-ΔCt relative to GAPDH